Cassandra Pardini, PharmD

Most Recent Articles by Cassandra Pardini, PharmD

Treatment Adherence in Schizophrenia: Which Antipsychotic Is Best?

By Apr 20, 2017

According to the adjusted results from a recent study, second generation antipsychotic long-acting injectable medications were linked to consistently more adherence and persistence when compared to oral antipsychotic patients.

Refractory Ulcerative Colitis in a Patient with NSAID Hypersensitivity

By Mar 22, 2017

The patient, a 33-year old woman with a history of drug hypersensitivity to NSAIDs and aspirin, presented for management of her chronic UC with mesalamine.

Exhalation Delivery System Compared to Conventional Nasal Spray

By Mar 06, 2017

EDS_FLU produced higher systemic exposure than Flonase and substantially lower systemic exposure than Flovent 440mcg, indicating that drug deposition is greatly improved with EDS vs. conventional nasal spray.

How Does Long-Term Attenuated Androgen Prophylaxis Affect Neoplasms, CVD Risk?

By Mar 06, 2017

Patients with hereditary angioedema (HAE) on long-term prophylaxis with attenuated androgen (LTP-AA) appeared to have a higher risk for cardiovascular disease but a lower number of neoplasms.

Recombinant HC1INH Safe, Effective for Preventing HAE Attacks

By Mar 06, 2017

Patients in the study were ≥13 years old, had a <50% of normal functional C1INH level, and a history of at least 4 monthly HAE attacks for at least 3 months.

More Articles by Cassandra Pardini, PharmD